Filed Pursuant to Rule 424(b)(5)
Registration No. 333-271504
PROSPECTUS SUPPLEMENT
(To
Prospectus dated April 28, 2023)
Up to $100 Million Maximum Aggregate Offering Price of Common Shares
SFL Corporation Ltd.
We entered into an Amended and Restated
At-the-Market Sales Agreement (the Sales Agreement) with BTIG, LLC (BTIG or the sales agent) on April 15, 2022, relating to
our common shares, par value $0.01 per share, or the common shares, offered by this prospectus supplement and the accompanying base prospectus. In accordance with the terms of the Sales Agreement, we may offer and sell common shares having an
aggregate offering price of up to $100,000,000 from time to time through BTIG, as our sales agent. As of the date of this prospectus supplement, no common shares have been sold under the Sales Agreement. In accordance with the terms of the Sales
Agreement, we are offering $100,000,000 common shares pursuant to this prospectus supplement and the accompanying prospectus.
Sales of common shares, if any, will be made in sales deemed to be an at-the-market offering as defined in Rule 415 promulgated under the Securities Act of 1933, as amended, or the Securities Act, including, without limitation, by means of ordinary brokers
transactions on the New York Stock Exchange, or the NYSE, at market prices, in block transactions, or as otherwise agreed upon by the sales agent and us.
We will pay the sales agent a commission of 1.0% of the gross proceeds of all sales of common shares for a per share price of less than or
equal to the daily volume weighted average price as reported by Bloomberg for such trading day (the Daily VWAP) and 1.25% of the gross proceeds of all sales of common shares for a per share price that are higher than the Daily
VWAP. The net proceeds from any sales under this prospectus supplement will be used as described under Use of Proceeds in this prospectus supplement.
In connection with the sales of our common shares on our behalf, BTIG may be deemed to be an underwriter within the
meaning of the Securities Act, and the compensation paid to BTIG may be deemed to be underwriting commissions or discounts. We have agreed in the Sales Agreement to provide indemnification and contribution to BTIG against certain liabilities,
including liabilities under the Securities Act.
Under the terms of the Sales Agreement, we also may sell common shares to
the sales agent as principal for its own account at a price agreed upon at the time of sale. If we sell common shares to the sales agent as principal, we will enter into a separate agreement with the sales agent, and we will describe this agreement
in a separate prospectus supplement or pricing supplement.
The sales agent is not required to sell any specific number or
dollar amount of our common shares, but will use commercially reasonable efforts, as our agent and subject to the terms of the Sales Agreement, to sell the common shares offered, as instructed by us. The offering of common shares pursuant to the
Sales Agreement will terminate upon the earlier of (1) the sale of all of the common shares subject to the Sales Agreement or (2) the termination of the Sales Agreement by either the sales agent or us.
Our common shares are listed on the NYSE under the symbol SFL. On April 27, 2023, the last reported
sale price of our common shares on the NYSE was $8.98 per share.
Investing in our common shares involves risks. You should carefully consider each of the factors described under Risk
Factors beginning on page S-4 of this prospectus supplement, on page 9 of the accompanying base prospectus and in the documents incorporated by reference into this prospectus supplement and the
accompanying base prospectus, before you make any investment in our common shares.
Neither the U.S. Securities and
Exchange Commission, or the Commission, nor any state securities commission has approved or disapproved of these securities, or determined if this prospectus supplement or the accompanying base prospectus is truthful or complete. Any representation
to the contrary is a criminal offense.
BTIG
Prospectus Supplement dated April 28, 2023